US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.800
  • +0.010+1.28%
Trading Aug 29 15:28 ET
166.60MMarket Cap-579P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
Single segment356K100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States176.23M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday+0.94%